Hyoungshin Park

Title: Hyoungshin Park: Innovator in Microfluidic Kidney-on-Chip Technology

Introduction

Hyoungshin Park is a prominent inventor based in Newton, MA (US), known for his significant contributions to the field of microfluidic devices. With a total of 8 patents to his name, he has made remarkable advancements in the development of kidney-on-chip technologies that have the potential to revolutionize drug testing and personalized medicine.

Latest Patents

One of Hyoungshin Park's latest patents is the Microfluidic Proximal Tubule Kidney-on-Chip. This invention relates to microfluidic fluidic devices, methods, and systems designed as kidney-on-chips, including the human Proximal Tubule-Kidney-Chip, Glomerulus (Kidney)-Chip, and Collecting Duct (Kidney)-Chip. The devices, methods, and systems described in this patent are utilized for drug testing, including drug transport and renal clearance. Furthermore, they are instrumental in determining drug-drug interactions and their effects on renal transporter functions. Importantly, these innovations may be applied in pre-clinical and clinical drug development for treating kidney diseases and advancing personalized medicine.

Career Highlights

Hyoungshin Park is currently employed at Emulate, Inc., where he continues to push the boundaries of microfluidic technology. His work has garnered attention for its potential impact on healthcare and drug development.

Collaborations

Hyoungshin collaborates with notable colleagues, including Geraldine A Hamilton and Catherine Karalis, who contribute to the innovative environment at Emulate, Inc.

Conclusion

Hyoungshin Park's work in microfluidic kidney-on-chip technology exemplifies the intersection of innovation and healthcare. His contributions are paving the way for advancements in drug testing and personalized medicine, ultimately benefiting patients with kidney diseases.